Status:
TERMINATED
Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
Lead Sponsor:
Nemours Children's Clinic
Collaborating Sponsors:
Alfred I. duPont Hospital for Children
Conditions:
Hepatoblastoma
Hepatocellular Carcinoma
Eligibility:
All Genders
Up to 21 years
Brief Summary
This study will be performed to evaluate the Clinical Outcomes and Quality of Life after Transarterial Radioembolization with Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults with Live...
Detailed Description
* Referral to Nemours Liver Tumor Program is made by the primary team (oncologist/surgeon). * Phone discussion between the Nemours Liver Tumor Program Team will occur with the referring team about the...
Eligibility Criteria
Inclusion
- Boys and girls age \< 21 years of age
- History of liver tumor
- Meet criteria for treatment with TARE-Y90
Exclusion
- • Inability to complete required study procedures.
Key Trial Info
Start Date :
February 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 28 2024
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04315883
Start Date
February 11 2021
End Date
March 28 2024
Last Update
June 12 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Nemours-AI duPont Hospital for Children
Wilmington, Delaware, United States, 19803
2
Nemours Children's Specialty Care
Jacksonville, Florida, United States, 32207